Eswatini vs Sur: New cases tested for RR-/MDR-TB
Eswatini
100.0%
in 2024
Sur
97.0%
in 2024
Eswatini rank
1st
Sur rank
1st
New cases tested for RR-/MDR-TB over time
- Eswatini
- Sur
How they compare
Eswatini currently reports 100.0% against 97.0% in Sur, a difference of 3.0%.
The two have swapped places 3 times across 14 shared years of data; in 2008 it was Sur ahead.
Eswatini ranks 1st and Sur ranks 1st of 192 countries.
Across the 3 decades both report, Eswatini averaged higher in 2 and Sur in 1.
Head to head by decade
| Decade | Eswatini | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36.3% | 26.3% | 10.0% | Eswatini |
| 2010s | 67.7% | 75.2% | 7.5% | Sur |
| 2020s | 100.0% | 97.2% | 2.8% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Eswatini or Sur?
- Eswatini, at 100.0% against 97.0% in Sur as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Eswatini and Sur?
- 3.0%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Sur?
- 14 years are reported by both, from 2008 to 2024.
- How do Eswatini and Sur rank globally for new cases tested for rr-/mdr-tb?
- Eswatini ranks 1st and Sur ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.